# AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 P&L / Income Statement

- Company: AXSOME THERAPEUTICS, INC. (AXSM)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-10, accession number 0001193125-26-342360
- Page: https://plicit.ai/financials/axsm/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/axsm-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 218,375,000 US dollars
- **Cost of revenue (calculated)**: 13,564,000 US dollars
- **Gross profit (calculated)**: 204,811,000 US dollars
- **Operating expenses (calculated)**: 254,457,000 US dollars
- **Loss from operations**: negative 49,646,000 US dollars
- **Other income (expense), net (calculated)**: negative 1,540,000 US dollars
- **Loss before income taxes**: negative 51,186,000 US dollars
- **Income tax benefit (expense)**: 128,000 US dollars
- **Net loss**: negative 51,314,000 US dollars
- **Royalty and Milestone Revenue - Outside of the United States**: 2,020,000 US dollars
- **Product Sales - UNITED STATES**: 215,367,000 US dollars
- **Product Sales - Outside of the United States**: 988,000 US dollars
- **Cost of revenue (excluding amortization and depreciation)**: 13,564,000 US dollars
- **Research and development**: 46,227,000 US dollars
- **Selling, general and administrative**: 208,137,000 US dollars
- **Gain in fair value of contingent consideration**: negative 1,496,000 US dollars
- **Intangible asset amortization**: 1,589,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/axsm/fy2026-q2-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/axsm-fy2026-q2-revenue-by-product-and-service-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 218,375,000 US dollars
- **Cost of revenue (calculated)**: 13,564,000 US dollars
- **Gross profit (calculated)**: 204,811,000 US dollars
- **Operating expenses (calculated)**: 254,457,000 US dollars
- **Loss from operations**: negative 49,646,000 US dollars
- **Other income (expense), net (calculated)**: negative 1,540,000 US dollars
- **Loss before income taxes**: negative 51,186,000 US dollars
- **Income tax benefit (expense)**: 128,000 US dollars
- **Net loss**: negative 51,314,000 US dollars
- **Product Sales**: 216,355,000 US dollars
- **Royalty and Milestone Revenue**: 2,020,000 US dollars
- **Cost of revenue (excluding amortization and depreciation)**: 13,564,000 US dollars
- **Research and development**: 46,227,000 US dollars
- **Selling, general and administrative**: 208,137,000 US dollars
- **Gain in fair value of contingent consideration**: negative 1,496,000 US dollars
- **Intangible asset amortization**: 1,589,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Counterparty Name

- Page: https://plicit.ai/financials/axsm/fy2026-q2-income-statement/revenue-by-counterparty-name
- Chart image: https://plicit.ai/charts/axsm-fy2026-q2-revenue-by-counterparty-name-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Counterparty Name. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 218,375,000 US dollars
- **Cost of revenue (calculated)**: 13,564,000 US dollars
- **Gross profit (calculated)**: 204,811,000 US dollars
- **Operating expenses (calculated)**: 254,457,000 US dollars
- **Loss from operations**: negative 49,646,000 US dollars
- **Other income (expense), net (calculated)**: negative 1,540,000 US dollars
- **Loss before income taxes**: negative 51,186,000 US dollars
- **Income tax benefit (expense)**: 128,000 US dollars
- **Net loss**: negative 51,314,000 US dollars
- **Auvelity**: 180,282,000 US dollars
- **Sunosi**: 33,820,000 US dollars
- **Symbravo**: 2,253,000 US dollars
- **Royalty and Milestone Revenue**: 2,020,000 US dollars
- **Cost of revenue (excluding amortization and depreciation)**: 13,564,000 US dollars
- **Research and development**: 46,227,000 US dollars
- **Selling, general and administrative**: 208,137,000 US dollars
- **Gain in fair value of contingent consideration**: negative 1,496,000 US dollars
- **Intangible asset amortization**: 1,589,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.